IGF1R and breast cancer: Interestingly, the EMT phenotype of these BC cells is characterized by: (i) overexpression of the epidermal growth factor receptor (EGFR) and of IGF-1R which form complex with ER-α; (ii) MAPK activation and, most importantly, (iii) increased resistance to tamoxifen.